Messrs. Glenn
Principal executive officer pay for Messrs. Glenn, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
IRADIMED CORP (IRMD) FY2022–FY2025
Aligned: paid up as stock roseCAP $586,040→$780,598 while $100 invested went $63.00→$368.00
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2022 | $586,040 | $586,040 |
| FY2023 | $642,566 | $642,566 |
| FY2024 | $689,580 | $689,580 |
| FY2025 | $780,598 | $780,598 |
The company's "$100 invested" index ran $63.00 at FY2022 → $368.00 by FY2025 — an annualized return of 80.1%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 80.1%/yr at IRMD ( FY2022–FY2025). See the CEO track-record ranking for context.